课题基金 / 基金详情

Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression

Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
细胞周期和肿瘤进展中的代谢、蛋白质和 miRNA 串扰
批准号:
8838733
负责人:
DAVID M. HOCKENBERY
金额:
$36.52万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-01 至 2016-03-31

项目摘要

项目成果

DAVID M. HOCKENBERY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In neoplastic diseases, cellular reprogramming for continued proliferation, invasion and metastasis are essential for tumor initation and progression. An increased understanding of oncogene regulation of these processes is essential to successful therapy. Our research has focused on the essential role of altered bioenergetics and biosynthetic metabolism during cell cycle entry and tumor progression regulated by the oncogene c-Myc. We have recently developed a novel approach to trace metabolism of nutrients and their direct contribution to protein modifications and demonstrated regulation of histone acetylation by substrate supply during Myc-dependent cell cycle entry, a previously unappreciated connection between metabolism and post-translational modifications. Increased lipid biosynthesis in Myc-expressing cells may increase protein targeting to lipid rafts and our preliminary studies indicate increased raft-associated Ras protein during Myc- induced cell cycle entry. We also demonstrated increased prostaglandin E2 in media, and that cyclooxygenase inhibitors had selective anti-proliferative effects for Myc-expressing cells. Lastly, our stable isotope studies with a Myc inducible/regressible tumor model show that tumor initiation, progression and regression are associated with distinct alterations in metabolic flux, setting up a potential for endogenous lipotoxicity from saturated fatty acids after Myc inactivation. These results lead us to hypothesize that Myc directs metabolism in synergistic pathways to promote cell cycling and cell growth, and that loss of this integration is a cause of Myc oncogene addiction. We propose the following specific aims to address these hypotheses. Specific Aim 1. To analyze changes in lipid raft composition during Myc-dependent cell cycle entry. Specific Aim 2. To analyze the requirements for arachidonic acid metabolism during Myc-dependent cell cycle entry. Specific Aim 3. To determine the role of lipotoxicity in Myc oncogene addiction. Together these studies have the potential to change current paradigms regarding control of signaling networks, to provide insight into proteins and miRNAs that participate in alteration of cell fates during programming of cells from quiescent to proliferative and tumorigenic states, and to reveal mechanisms underlying oncogene addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer
  • 批准号:
    10603025
  • 项目类别:
  • 资助金额:
    $16.13万
  • 财政年份:
    2017
  • 负责人:
    DAVID M. HOCKENBERY
  • 依托单位:
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
海外基金